January 2023

How CANTAB can be used to overcome challenges in assessing cognition in people with intellectual disabilities

Insights Back to resource centre 17 January 2023 How CANTAB can be used to overcome challenges in assessing cognition in people with intellectual disabilities Operational scientist Eleanor Rist explores how CANTAB™ assessments can be beneficial for studies involving people with intellectual disabilities. Intellectual disabilities, often referred to as learning disabilities in the UK, are generally defined as having an IQ

Cambridge Cognition and Winterlight Labs join forces to lead in voice and digital biomarkers for clinical trials

News Back to resource centre 11 January 2023 Cambridge Cognition and Winterlight Labs join forces to lead in voice and digital biomarkers for clinical trials Cambridge Cognition, which develops and markets digital solutions to assess brain health, is pleased to announce its acquisition of Winterlight, a leader in monitoring cognitive impairment through free-speech analysis.Both Cambridge Cognition and Winterlight share a

Using CANTAB to assess cognitive function in long-term Hodgkin lymphoma survivors

Insights Back to resource centre 6 January 2023 Using CANTAB to assess cognitive function in long-term Hodgkin lymphoma survivors We caught up with Dr Ferenc Magyari from the University of Debrecen, who told us how CANTAB™ has helped them to understand the long-term cognitive impact of Hodgkin’s Lymphoma. I started working as an internal medicine resident doctor at the University

Scroll to Top